Unknown

Dataset Information

0

Macrophage Subpopulation Dynamics Shift following Intravenous Infusion of Mesenchymal Stromal Cells.


ABSTRACT: Intravenous infusion of mesenchymal stromal cells (MSCs) is thought to be a viable treatment for numerous disorders. Although the intrinsic immunosuppressive ability of MSCs has been credited for this therapeutic effect, their exact impact on endogenous tissue-resident cells following delivery has not been clearly characterized. Moreover, multiple studies have reported pulmonary sequestration of MSCs upon intravenous delivery. Despite substantial efforts to improve MSC homing, it remains unclear whether MSC migration to the site of injury is necessary to achieve a therapeutic effect. Using a murine excisional wound healing model, we offer an explanation of how sequestered MSCs improve healing through their systemic impact on macrophage subpopulations. We demonstrate that infusion of MSCs leads to pulmonary entrapment followed by rapid clearance, but also significantly accelerates wound closure. Using single-cell RNA sequencing of the wound, we show that following MSC delivery, innate immune cells, particularly macrophages, exhibit distinctive transcriptional changes. We identify the appearance of a pro-angiogenic CD9+ macrophage subpopulation, whose induction is mediated by several proteins secreted by MSCs, including COL6A1, PRG4, and TGFB3. Our findings suggest that MSCs do not need to act locally to induce broad changes in the immune system and ultimately treat disease.

SUBMITTER: Kosaric N 

PROVIDER: S-EPMC7474342 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Macrophage Subpopulation Dynamics Shift following Intravenous Infusion of Mesenchymal Stromal Cells.

Kosaric Nina N   Srifa Waracharee W   Bonham Clark A CA   Kiwanuka Harriet H   Chen Kellen K   Kuehlmann Britta A BA   Maan Zeshaan N ZN   Noishiki Chikage C   Porteus Matthew H MH   Longaker Michael T MT   Gurtner Geoffrey C GC  

Molecular therapy : the journal of the American Society of Gene Therapy 20200530 9


Intravenous infusion of mesenchymal stromal cells (MSCs) is thought to be a viable treatment for numerous disorders. Although the intrinsic immunosuppressive ability of MSCs has been credited for this therapeutic effect, their exact impact on endogenous tissue-resident cells following delivery has not been clearly characterized. Moreover, multiple studies have reported pulmonary sequestration of MSCs upon intravenous delivery. Despite substantial efforts to improve MSC homing, it remains unclear  ...[more]

Similar Datasets

2016-02-01 | GSE76081 | GEO
| S-EPMC7773587 | biostudies-literature
| S-EPMC3868307 | biostudies-literature
| S-EPMC4127236 | biostudies-literature
| S-EPMC10917976 | biostudies-literature
| S-EPMC4239576 | biostudies-literature
| S-EPMC6758577 | biostudies-literature
| S-EPMC9331786 | biostudies-literature
| S-EPMC10093665 | biostudies-literature
| S-EPMC8920534 | biostudies-literature